Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography–tandem mass spectrometry
- 1 March 2010
- journal article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 878 (7-8), 675-681
- https://doi.org/10.1016/j.jchromb.2010.01.037
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Status epilepticus: A critical reviewEpilepsy & Behavior, 2009
- Levetiracetam in children with refractory status epilepticusEpilepsy & Behavior, 2009
- Off-Label Use of Antiepileptic Drugs for the Treatment of Neonatal SeizuresPediatric Neurology, 2008
- Drug Monitoring: Simultaneous Analysis of Lamotrigine, Oxcarbazepine, 10-Hydroxycarbazepine, and Zonisamide by HPLC-UV and a Rapid GC Method Using a Nitrogen-Phosphorus Detector for LevetiracetamJournal of Chromatographic Science, 2007
- Levetiracetam: Part II, the Clinical Profile of a Novel Anticonvulsant DrugCNS Drug Reviews, 2007
- Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant proteinEuropean Journal of Pharmacology, 2006
- Determination of levetiracetam in human plasma with minimal sample pretreatmentJournal of Chromatography B, 2005
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Neonatal seizures and their treatmentCurrent Opinion in Neurology, 2003
- Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000